Stevens-Johnson Syndrome: Why a Rash With Mouth Sores Is a Medical Emergency

Sudha Mishra | Updated:
Share
Mouth rash
Mouth rash

Most rashes are inconvenient. Stevens-Johnson Syndrome is different, it begins with what looks like a bad flu, then progresses to blistering skin and painful mouth ulcers within days. Understanding what drives this reaction, which drugs most commonly trigger it, and why the timing of care changes outcomes is information worth having before you need it.

Highlights
  • Stevens-Johnson Syndrome is a severe mucocutaneous reaction that can lead to rapid tissue damage, making immediate medical assessment crucial.
  • Common drugs linked to Stevens-Johnson Syndrome include certain anticonvulsants such as carbamazepine and lamotrigine, sulfonamide antibiotics, and allopurinol, highlighting the importance of monitoring new rashes after starting any medication.
  • Symptoms such as fever, sore throat, and burning eyes may precede the rash of Stevens-Johnson Syndrome, and any rash with mouth sores or eye involvement should prompt urgent medical evaluation.
Stevens-Johnson Syndrome sits at the severe end of a spectrum of drug-triggered skin reactions that dermatologists treat as emergencies from the first hour. The condition is rare, but its progression is fast enough that the window between first symptoms and serious tissue damage can be measured in days rather than weeks. Knowing its pattern does not make it self-diagnosable, it makes it recognisable as something that cannot wait for a scheduled appointment.

What Is Actually Happening in the Skin

Stevens-Johnson Syndrome, abbreviated SJS, is a severe mucocutaneous reaction, meaning it affects both the skin and the mucous membranes that line the mouth, eyes, and genitals. In most confirmed cases, the immune system mounts an abnormal, destructive response to a drug or, less commonly, to an infection. The result is widespread death of keratinocytes, the cells that make up the outer layer of skin. As those cells die, the skin separates from the dermis below it, forming blisters that rupture and leave raw, open surfaces behind.

The condition sits on a spectrum. When less than ten percent of the body surface area is affected, it is classified as SJS. When more than thirty percent is involved, it is called Toxic Epidermal Necrolysis, or TEN. The overlap zone between ten and thirty percent is called SJS-TEN overlap. All three are the same underlying process at different scales, and all three are medical emergencies.

The Warning Signs That Precede the Rash

SJS rarely announces itself with blisters first. The prodrome, the period before the skin reacts, looks like a severe upper respiratory infection. Fever, sore throat, burning eyes, and generalised fatigue appear one to three weeks after starting a new drug. This timing matters: the drug causing the reaction has usually been in the system for days before symptoms begin, which is why patients often do not connect the two.

The skin component follows. Flat, dark red or purplish patches appear first, typically on the face and upper trunk, then spread. A key clinical sign is the Nikolsky sign: when gentle lateral pressure is applied to apparently unaffected skin near a lesion, the outer layer slides off. Mouth ulcers, eye redness and crusting, and pain on swallowing are present in nearly all SJS cases and are among the features that separate it from other drug rashes. Any rash accompanied by mouth involvement, eye involvement, or fever should be treated as potentially serious until a clinician rules otherwise.

Which Drugs Are Most Commonly Implicated

The drugs most consistently linked to SJS in published case data include certain anticonvulsants, carbamazepine and lamotrigine among them, sulfonamide antibiotics, allopurinol used for gout, and some non-steroidal anti-inflammatory drugs, particularly those in the oxicam class. Nevirapine, used in HIV treatment, also carries a documented association. This is not an exhaustive list, and SJS has been reported with a wide range of medications. The point is not to avoid these drugs, many are essential, but to understand that any new rash appearing within weeks of starting a new medication is a reason to contact a doctor the same day, not wait to see if it settles.

Certain genetic variants affect how the body metabolises specific drugs, which is why SJS risk is not uniform across populations. The HLA-B*1502 allele, which is more common in people of Han Chinese, Thai, and some South Asian ancestry, is strongly associated with carbamazepine-induced SJS. Some countries now recommend genetic screening before prescribing carbamazepine to patients from these populations. If you are starting a new anticonvulsant and your prescribing doctor has not mentioned this, it is a reasonable question to ask.

Why Timing of Care Changes the Outcome

SJS is treated in hospital, typically in a burns unit or intensive care setting, because the open skin surfaces carry the same risks as burns: fluid loss, infection, and temperature dysregulation. The first and most critical step is identifying and stopping the causative drug immediately. Every additional dose after the reaction has started extends the damage.

Supportive care, fluid replacement, wound management, nutritional support, and eye care, forms the core of treatment. The evidence for specific immunosuppressive drugs in SJS is still evolving, and treatment decisions depend on the severity, the stage at presentation, and the individual patient's condition. This is a clinical judgement made by specialists, not a protocol that can be described here. What is consistent across the literature is that outcomes are significantly worse when diagnosis is delayed and the causative drug continues to be taken.

Long-term complications affect the eyes in a significant proportion of survivors, ranging from chronic dryness to scarring of the conjunctiva. Skin, mucous membranes, and the airways can also carry lasting changes. The severity of complications correlates with how much of the body surface was involved and how quickly appropriate care began.

When to Stop Waiting and Go

SJS cannot be diagnosed at home, and this article is not a diagnostic tool. What it can do is describe the pattern clearly enough that a reader recognises when something is wrong in a way that requires emergency evaluation rather than a GP appointment next week.

Go to an emergency department, not an urgent care clinic, an emergency department, if a rash is spreading rapidly and accompanied by any of the following: mouth sores or difficulty swallowing, eye pain or redness, fever above 38.5°C, or skin that feels like it is peeling or blistering. Bring a list of every medication started in the past four to six weeks, including over-the-counter drugs and supplements. A dermatologist or emergency physician needs to assess the full clinical picture. Self-treating a rash of this pattern with antihistamines or topical creams is not appropriate and wastes the time that matters most in this condition.

Discover expert advice and the latest updates in Skin Care, Hair Care, Wellness, Dermatology, and more at Stay Young guide to lasting beauty and holistic health!